ES2062271T3 - Preparaciones farmaceuticas. - Google Patents

Preparaciones farmaceuticas.

Info

Publication number
ES2062271T3
ES2062271T3 ES90122574T ES90122574T ES2062271T3 ES 2062271 T3 ES2062271 T3 ES 2062271T3 ES 90122574 T ES90122574 T ES 90122574T ES 90122574 T ES90122574 T ES 90122574T ES 2062271 T3 ES2062271 T3 ES 2062271T3
Authority
ES
Spain
Prior art keywords
weight
denotes
pharmaceutical preparations
polyloxyethylene
pyrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90122574T
Other languages
English (en)
Inventor
Walter Fries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MACK CHEM PHARM
Heinrich Mack Nachf GmbH and Co
Original Assignee
MACK CHEM PHARM
Heinrich Mack Nachf GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MACK CHEM PHARM, Heinrich Mack Nachf GmbH and Co filed Critical MACK CHEM PHARM
Application granted granted Critical
Publication of ES2062271T3 publication Critical patent/ES2062271T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Abstract

UNA PREPARACION FARMACEUTICA PARA ADMINISTRACION PARENTERAL DE UNA DROGA QUE CONSISTE EN UN SISTEMA DISOLVENTE QUE CONTIENE: (A) DEL 0 AL 65 % DE SU PESO DE A-TETRAHIDROFURFURIL-W-HIDROXI -POLILOXIETILENO; (B) DEL 10 AL 100 % DE SU PESO DE GLICOL POLIETILENO CON UN PESO MEDIO MOLECULAR DE 200 A 600; Y (C) DEL 0 AL 35 % DE SU PESO DE AGUA. LA SUMA DE LOS COMPONENTES (A) Y (B) QUE ASCIENDE HASTA AL MENOS EL 65 % DE SU PESO, Y DE UNO O MAS COMPUESTOS TERAPEUTICAMENTE ACTIVOS DE LA FORMULA DONDE R SUB 1 DENOTA UN RADICAL FENILICO SUSTITUIDO OPCIONALMENTE POR 1 A 3 SUSTITUTOS SELECCIONADOS INDEPENDIENTEMENTE DE UN GRUPO CONSTITUIDO POR F, CL, BR, I, CF SUB 3, C SUB 1 A C SUB 4 ALKIL Y C SUB 1 A C SUB 4 ALKOXI , O 5-CLOROPIRIDIO-2-YL; X DENOTA OH, F, CL O BR; R SUB 2 ES H, CH SUB 3 O F; Y R SUB 3 ES H O F.
ES90122574T 1989-11-29 1990-11-26 Preparaciones farmaceuticas. Expired - Lifetime ES2062271T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
ES2062271T3 true ES2062271T3 (es) 1994-12-16

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90122574T Expired - Lifetime ES2062271T3 (es) 1989-11-29 1990-11-26 Preparaciones farmaceuticas.

Country Status (29)

Country Link
US (1) US5118698A (es)
EP (1) EP0430149B1 (es)
JP (1) JPH0660097B2 (es)
KR (1) KR940000066B1 (es)
CN (1) CN1035357C (es)
AT (1) ATE102051T1 (es)
AU (1) AU626480B2 (es)
BR (1) BR9006025A (es)
CA (1) CA2030911C (es)
CY (1) CY1970A (es)
CZ (1) CZ282898B6 (es)
DE (2) DE3939492A1 (es)
DK (1) DK0430149T3 (es)
EG (1) EG19557A (es)
ES (1) ES2062271T3 (es)
FI (1) FI103713B (es)
HK (1) HK216896A (es)
HU (1) HU220867B1 (es)
IE (1) IE64672B1 (es)
IL (1) IL96450A (es)
MX (1) MX23518A (es)
MY (1) MY104540A (es)
NO (1) NO180475C (es)
NZ (1) NZ236255A (es)
PT (1) PT96003B (es)
RU (1) RU2038080C1 (es)
SK (1) SK280599B6 (es)
YU (1) YU227290A (es)
ZA (1) ZA909549B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
AU7880991A (en) * 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
ES2331058T3 (es) * 2001-02-28 2009-12-21 Intervet International Bv Emulsiones de agua en aceite inyectables.
AU2003210517A1 (en) 2002-02-04 2003-09-02 Elan Pharma International, Ltd. Drug nanoparticles with lysozyme surface stabiliser
EP1551457A1 (en) * 2002-07-16 2005-07-13 Elan Pharma International Limited Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (es) * 1982-06-09 1984-10-22 Pfizer
AU4882685A (en) * 1984-10-19 1986-04-24 Schering Corporation 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4- difluorophenyl) propane

Also Published As

Publication number Publication date
CA2030911A1 (en) 1991-05-30
SK595390A3 (en) 2000-04-10
FI905814A0 (fi) 1990-11-26
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
DE69007029T2 (de) 1994-06-09
PT96003A (pt) 1991-09-13
DK0430149T3 (da) 1994-03-28
NO180475B (no) 1997-01-20
CN1052046A (zh) 1991-06-12
EP0430149A2 (en) 1991-06-05
BR9006025A (pt) 1991-09-24
CY1970A (en) 1997-09-05
NZ236255A (en) 1992-02-25
IE904282A1 (en) 1991-06-05
NO905106L (no) 1991-05-30
DE3939492A1 (de) 1991-06-06
ZA909549B (en) 1992-06-24
IL96450A (en) 1994-10-21
US5118698A (en) 1992-06-02
HUT57039A (en) 1991-11-28
SK280599B6 (sk) 2000-04-10
ATE102051T1 (de) 1994-03-15
IE64672B1 (en) 1995-08-23
JPH0660097B2 (ja) 1994-08-10
CN1035357C (zh) 1997-07-09
HU220867B1 (en) 2002-06-29
RU2038080C1 (ru) 1995-06-27
FI905814A (fi) 1991-05-30
EG19557A (en) 1997-08-31
NO180475C (no) 1997-04-30
NO905106D0 (no) 1990-11-26
JPH03176421A (ja) 1991-07-31
YU227290A (sh) 1993-10-20
CZ282898B6 (cs) 1997-11-12
EP0430149A3 (en) 1991-09-25
KR940000066B1 (ko) 1994-01-05
EP0430149B1 (en) 1994-03-02
HK216896A (en) 1996-12-27
AU6706590A (en) 1991-08-08
FI103713B (fi) 1999-08-31
MX23518A (es) 1993-04-01
KR910009286A (ko) 1991-06-28
CZ595390A3 (en) 1997-06-11
AU626480B2 (en) 1992-07-30
MY104540A (en) 1994-04-30
PT96003B (pt) 1998-01-30
CA2030911C (en) 1995-02-07

Similar Documents

Publication Publication Date Title
ATE68180T1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69011569T2 (de) Verbindungen der 1-Azabicyclo(3.2.0)hept-2-en-2-carbonsäure.
IL77717A (en) Pharmaceutical compositions containing derivatives of imidazole,their preparation and some novel compounds of this type
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
SE7906472L (sv) Nya 3-(aminoetyl)-fenol-derivat och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
FR2669927B1 (fr) Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FI881816A0 (fi) Nya bicykliska foereningar, foerfarane foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
DE69007029D1 (de) Arzneimittelzubereitungen.
FI104071B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents£b|atsepiinijohdannaisten valmistamiseksi
DK451389A (da) 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser
MX9206930A (es) Nuevos compuestos
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
FR2682952B1 (fr) Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
SE9402596L (sv) Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa föreningar
KR890013001A (ko) 자극성 아미노산 수용체 길항제인 테트라졸 유도체

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 430149

Country of ref document: ES